← All companies

MSLE

Satellos Bioscience Inc.

MSLE Nasdaq Pharmaceutical Preparations EDGAR ↗

$8.60

-0.21 -2.38%

Key statistics

from XBRL data in SEC filings

Market cap ⓘ

$133M

Revenue (TTM) ⓘ

—

Net income (TTM) ⓘ

—

EPS (TTM) ⓘ

—

P/E ratio ⓘ

—

Dividend yield ⓘ

—

Free cash flow ⓘ

—

Cash ⓘ

—

Total assets ⓘ

—

Gross margin ⓘ

—

52-week range ⓘ

$5.30 – $13.40

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K Sep 24, 2026

6-K FORM 6-K Sep 15, 2026

6-K FORM 6-K Sep 9, 2026

6-K FORM 6-K Sep 1, 2026

6-K FORM 6-K Aug 14, 2026

6-K FORM 6-K Aug 13, 2026

6-K FORM 6-K Jul 8, 2026

6-K FORM 6-K Jun 29, 2026

6-K FORM 6-K Jun 25, 2026

6-K FORM 6-K Jun 18, 2026

6-K FORM 6-K Jun 17, 2026

6-K FORM 6-K May 27, 2026

6-K FORM 6-K May 20, 2026

6-K FORM 6-K May 15, 2026

6-K FORM 6-K Apr 9, 2026

40-F Mar 27, 2026

6-K FORM 6-K Mar 27, 2026

6-K FORM 6-K Mar 10, 2026

6-K FORM 6-K Feb 24, 2026

6-K FORM 6-K Feb 19, 2026

6-K FORM 6-K Feb 18, 2026

6-K FORM 6-K Feb 17, 2026

6-K FORM 6-K Feb 12, 2026

6-K FORM 6-K Feb 10, 2026

6-K FORM 6-K Feb 10, 2026

6-K FORM 6-K Feb 6, 2026

Other filings

SUPPL Aug 14, 2026

F-X FORM F-X Aug 11, 2026

F-10 Aug 11, 2026

SCHEDULE 13G May 15, 2026

SCHEDULE 13G May 12, 2026

S-8 FORM S-8 Mar 27, 2026

SUPPL Feb 6, 2026

CERT Feb 6, 2026

8-A12B Feb 5, 2026

F-X FORM F-X Feb 5, 2026

F-10 Feb 5, 2026

D Item 06b Jan 3, 2025

D Item 06b May 25, 2023

D Item 06b Sep 27, 2022